Resources on COVID-19 Monoclonal Antibody Therapeutics From Combat Covid

Resources on COVID-19 Monoclonal Antibody Therapeutics From Combat Covid.

  • Combat Covid accessed August 8,2021 from HHS.gov
    • JOIN THE FIGHT
      Find ways to prevent, treat or help fight COVID-19.

    • FEATURED RESOURCES
      • 1 Woman’s Amazing Recovery From COVID-19. [Link is to the YouTube video] Find Treatments and Recovery Options If You Test Positive.
        1,243 views Jul 21, 2021

        • “Watch a video about the real-life story of one woman who was sick with COVID-19—and her decision to join a clinical trial that made all the difference. “
        • “The incredible, real-life story of one Latina woman’s decision to act fast and join a clinical trial that kept her out of the hospital when she tested positive and got sick with COVID-19.
        • Visit https://go.usa.gov/xFgF8 and learn all the latest options available near you so you can choose your best steps to help you recover faster.”
        • Find clinical trials
      • Dr. Rachel Levine: The Importance of MonoclonalAntibody Treatment for COVID-19 [Link is to the YouTube video]
        9,048 views Jul 9, 2021

        • “Dr. Rachel Levine, Assistant Secretary for Health, discusses how clinicians should counsel their patients on monoclonal antibody treatment for COVID-19.
        • “Clinicians and healthcare providers discuss the challenges they faced at the on set of the COVID-19 pandemic and the role monoclonal antibody treatment played in improving outcomes for their high-risk patients. “
        • For more resources on monoclonal antibody treatment, visit https://go.usa.gov/x6tV7. For more information, healthcare professionals can visit https://go.usa.gov/x6tVs. To find out if you or a loved one may be eligible for monoclonal antibody treatment and to locate a nearby infusion center, visit https://go.usa.gov/x6tVM.”
        • Learn about treatment
      • Equitable Access to Monoclonal Antibody Treatment for COVID-19 [Link is to the YouTube video]
        172 views Jul 26, 2021

      • Improved Patient Outcomes: Monoclonal Antibody Treatment for COVID-19 [Link is to YouTube video]
        107 views Aug 5, 2021

        • “Clinicians and healthcare providers discuss the challenges they faced at the onset of the COVID-19 pandemic and the role monoclonal antibody treatment played in improving outcomes for their high-risk patients.”
        • For more resources on monoclonal antibody treatment, visit https://go.usa.gov/xFNeg., For more information, healthcare professionals can visit https://go.usa.gov/xFNeT. To find out if you or a loved one may be eligible for monoclonal antibody treatment and to locate a nearby infusion center, visit https://go.usa.gov/xFNej.
    • LEARN WHAT YOU CAN DO
      • “You or Your Loved One Have COVID-19 Now
        People with the disease can help in the fight against COVID-19 by participating in a clinical trial to find effective ways to treat the disease.”

      • “Monoclonal Antibody Treatment
        If you’ve tested positive for COVID-19, one of the first questions you may have is, What can I do to reduce the risk of getting sicker? There are treatments that may reduce that risk.”

      • “Learn About the COVID-19 Vaccines
        Get key information on COVID-19 vaccines including effectiveness, safety, availability, and cost.”

    • INFORMATION FOR HEALTHCARE PROFESSIONALS
      • “COVID-19 Resources for Healthcare Professionals
        Find up-to-date information on COVID-19 treatment options, including monoclonal antibodies (mAbs) and clinical trials.”

      • “Monoclonal Antibody Resources for Clinicians
        Find information that may help your high-risk COVID-19 patients avoid or reduce hospitalization.”

      • “Videos on Monoclonal Antibodies
        Explore the resources.”

Public Health Emergency: Bamlanivimab/etesevimab [distribution paused] accessed August 8, 2021 from Pubic

Emergency.

COVID-19 Monoclonal Antibody Therapeutics  (accessed August 8, 2021)  from Pubic Health Emergency.

REGEN-COV Authorized by FDA for Post-Exposure Prophylaxis under Emergency Use Authorization (accessed August 8, 2021) from Pubic Health Emergency.

On July 30, 2021, the FDA authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab). The REGEN-COV Emergency Use Authorization (EUA) has been expanded to include post-exposure prophylaxis. FDA’s authorization of a therapeutic product for post-exposure prophylaxis is a significant advancement in the COVID-19 response that supplements vaccination for disease prevention. Learn More >>

Commercial Resources From Eli Lilly:

This entry was posted in COVID-19, COVID-19 Treatment, COVID-19 Treatment Trials, Infectious Diseases. Bookmark the permalink.